PharmAthene, Inc. (PIP) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for PIP, as the stock is now down over 29% in the past one-month time frame.
This biodefense company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
PharmAthene currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.
Some better-ranked stocks in the same sector include Astellas Pharma, Inc. (ALPMY), Grifols, S.A. (GRFS) and Cardiome Pharma Corp. (CRME). Astellas Pharma and Cardiome Pharma carry a Zacks Rank #2 (Buy) while Grifols carries Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
This biodefense company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
PharmAthene currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.
Some better-ranked stocks in the same sector include Astellas Pharma, Inc. (ALPMY), Grifols, S.A. (GRFS) and Cardiome Pharma Corp. (CRME). Astellas Pharma and Cardiome Pharma carry a Zacks Rank #2 (Buy) while Grifols carries Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
ASTELLAS PHARMA (ALPMY): Get Free Report
CARDIOME PHARMA (CRME): Get Free Report
GRIFOLS SA-ADR (GRFS): Free Stock Analysis Report
PHARMATHENE INC (PIP): Get Free Report
To read this article on Zacks.com click here.